Overall Learning Objectives
At the conclusion of the series, participants should be able to:
Session Learning Objectives
At the conclusion of this session, participants should be able to:
FINANCIAL DISCLOSURES
Planning Committee
Monica Giovanni, MS, CGC, Geisinger Health System, Brookline, MA Nothing to disclose
Christian Schaaf, MD, PhD, FACMG- Baylor College of Medicine and Jan & Dan Duncan Neurological Research Institute, Houston, TX Dr. Schaaf is employed at Baylor College of Medicine (BCM); BCM has a joint venture with Baylor Miraca Genetic Laboratories
Adult Genetics SIG webinar workgroup
Fernando Arena, MD, FACMG-TX Dept of State Health Services Nothing to disclose
Shweta Dhar, MD, MS, FACMG – Baylor College of Medicine Dr. Dhar is owner & co-founder of PanGenomics, India
Tanya Eble, MS, CGC – Baylor College of Medicine Ms. Eble is employed at Baylor College of Medicine (BCM); BCM has a joint venture with Baylor Miraca Genetic Laboratories
Fuki Hisama, MD, FACMG – Univ of Washington, Seattle Dr. Hisama is a consultant for Horizon pharmaceuticals
Matthew Taylor, MD, FACMG – Univ of Colorado, Denver Dr. Taylor has Grant/Research Support; Genzyme/Sanofi, Shire Therapeutics, Amicus Therapeutics, Bristol Myers Squibb, Consultant; GeneDx
Jaime Vengoechea, MD, FACMG – Emory University Nothing to disclose
Staff
Jane Radford, MHA, CHCP Nothing to disclose
Faculty Disclosures
All presenters are currently employed at Baylor College of Medicine (BCM); BCM has a joint venture with Baylor Miraca Genetic Laboratories
Shweta Dhar, MD, MS, FACMG Dr. Dhar is owner & Co-founder of PanGenomics, India
Deanna Erwin, MS, CGC – Nothing to disclose
Tanya Eble is a consultant for PanGenomics, India
Dihong Zhou – Nothing to disclose
© 2023 American College of Medical Genetics and Genomics. All rights reserved.